EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 20 / No 1 (Janvier 2004) Med Sci (Paris), 20 1 (2004) 55-60 References
Free Access
Issue
Med Sci (Paris)
Volume 20, Number 1, Janvier 2004
Page(s) 55 - 60
Section M/S revues
DOI https://doi.org/10.1051/medsci/200420155
Published online 15 January 2004
  1. Vaillant C, Didier-Bazes M, Hutter A, Belin MF, Thomasset N. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. J Neurosci 1999; 19 : 4994–5004. [Google Scholar]
  2. Jaworski DM. Developmental regulation of membrane type-5 matrix metalloproteinase (MT5-MMP) expression in the rat nervous system. Brain Res 2000; 860 : 174–7. [Google Scholar]
  3. Rivera S, Khrestchatisky M. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuronal plasticity and pathology. In : Baudry M, Thomsom RF, Davis JL, eds. Advances in synaptic plasticity. Cambridge, MA : The MIT Press, 1999 : 53–86. [Google Scholar]
  4. Galko MJ, Tessier-Lavigne M. Function of an axonal chemoattractant modulated by metalloprotease activity. Science 2000; 289 : 1365–7. [Google Scholar]
  5. Webber CA, Hocking JC, Yong VW, Stange CL, McFarlane S. Metalloproteases and guidance of retinal axons in the developing visual system. J Neurosci 2002; 22 : 8091–100. [Google Scholar]
  6. Llano E, Pendas AM, Aza-Blanc P, Kornberg TB, Lopez-Otin C. Dm1-MMP, a matrix metalloproteinase from Drosophila with a potential role in extracellular matrix remodeling during neural development. J Biol Chem 2000; 275 : 35978–85. [Google Scholar]
  7. Hattori M, Osterfield M, Flanagan JG. Regulated cleavage of a contact-mediated axon repellent. Science 2000; 289 : 1360–5. [Google Scholar]
  8. Rivera S, Tremblay E, Timsit S, Canals O, Ben-Ari Y, Khrestchatisky M. Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures : evidence for developmental, immediate early gene, and lesion response. J Neurosci 1997; 17 : 4223–35. [Google Scholar]
  9. Rivera S, Ogier C, Jourquin J, et al. Gelatinase B and TIMP-1 are regulated in a cell- and time dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur J Neurosci 2002; 15 : 19–32. [Google Scholar]
  10. Szklarczyk A, Lapinska J, Rylski M, McKay RD, Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J Neurosci 2002; 22 : 920–30. [Google Scholar]
  11. Jourquin J, Tremblay E, Decanis N, et al. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur J Neurosci 2003; 18 : 1507–17. [Google Scholar]
  12. Vos CM, Sjulson L, Nath A, et al. Cytotoxicity by matrix metalloprotease-1 in organotypic spinal cord and dissociated neuronal cultures. Exp Neurol 2000; 163 : 324–30. [Google Scholar]
  13. Gu Z, Kaul M, Yan B, et al. S-nitrosylation of matrix metalloproteinases : signaling pathway to neuronal cell death. Science 2002; 297 : 1186–90. [Google Scholar]
  14. Chapman GA, Moores K, Harrison D, Campbell CA, Stewart BR, Strijbos PJ. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J Neurosci 2000; 20 : RC87. [Google Scholar]
  15. Ethell DW, Kinloch R, Green DR. Metalloproteinase shedding of Fas ligand regulates beta-amyloid neurotoxicity. Curr Biol 2002; 12 : 1595–600. [Google Scholar]
  16. Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, Bredesen DE. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 1998; 395 : 801–4. [Google Scholar]
  17. Noble LJ, Donovan F, Igarashi T, Goussev S, Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci 2002; 22 : 7526–35. [Google Scholar]
  18. Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001; 21 : 7724–32. [Google Scholar]
  19. Graesser D, Mahooti S, Madri JA. Distinct roles for matrix metalloproteinase-2 and alpha4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis. J Neuroimmunol 2000; 109 : 121–31. [Google Scholar]
  20. Opdenakker G, Van den Steen PE, Van Damme J. Gelatinase B : a tuner and amplifier of immune functions. Trends Immunol 2001; 22 : 571–9. [Google Scholar]
  21. D’Souza CA, Mak B, Moscarello MA. The up-regulation of stromelysin-1 (MMP-3) in a spontaneously demyelinating transgenic mouse precedes onset of disease. J Biol Chem 2002; 277 : 13589–96. [Google Scholar]
  22. Giraudon P, Szymocha R, Buart S, et al. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes : relevance to HTLV-I-induced neurological disease. J Immunol 2000; 164 : 2718–27. [Google Scholar]
  23. Yong, VW, Power C, Forsyth P, Edwards DR. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001; 2 : 502–11. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.